Local Recurrence Due to Rectal Cancer in Sweden

Last updated: November 3, 2023
Sponsor: Sahlgrenska University Hospital, Sweden
Overall Status: Active - Recruiting

Phase

N/A

Condition

Rectal Cancer

Digestive System Neoplasms

Colorectal Cancer

Treatment

Treatment for local recurrence with surgery or other treatments

Clinical Study ID

NCT04404777
LERIS
  • Ages > 18
  • All Genders

Study Summary

The aim of this retrospective national registry study is to validate the reporting of local recurrence in the registry. Another aim is to identify preoperative risk factors for local recurrence. This can in turn indicate the need for a more intense follow-up. The treatment of local recurrence, including the impact of the multidisciplinary team conference (MDT) and the surgical procedure and the referral pathways of local recurrences will also be determined.

We aim to evaluate treatment outcome after local recurrence for patients operated or treated between 2007-2018.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Rectal cancer with a curative intent

Exclusion

Exclusion Criteria:

  • Rectal cancer without curative intent

Study Design

Total Participants: 12000
Treatment Group(s): 1
Primary Treatment: Treatment for local recurrence with surgery or other treatments
Phase:
Study Start date:
July 01, 2022
Estimated Completion Date:
August 01, 2025

Connect with a study center

  • Dept. of Surgery, Sahlgrenska University Hospital/Ostra

    Gothenburg, SE 416 85
    Sweden

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.